Company Monitoring Page for Eli-Lilly

latest headlines for company on cafepharma

FDA declines to approve Eli Lilly's bowel disease drug
Yahoo/Reuters
Thu, 04/13/23 - 10:19 pm
Tags:
Eli Lilly, IBD, FDA, mirikizumab
Bernie Sanders weighs Senate hearing for largest insulin makers
Seeking Alpha
Thu, 04/13/23 - 11:53 am
Tags:
Bernie Sanders, diabetes, insulin, drug pricing, Eli Lilly, Sanofi, Novo Nordisk, Senate
Eli Lilly Spends Big on First Mounjaro TV Commercial for Diabetes
Xtalks
Fri, 04/7/23 - 01:42 pm
Tags:
Eli Lilly, Mounjaro, DTC ads, television ads, diabetes
Diabesity drugs and their free ‘contract sales force’
Medical Marketing and Media
Tue, 04/4/23 - 10:12 am
Tags:
Novo Nordisk, Eli Lilly, diabetes, obesity, telehealth, social media, Mounjaro, Wegovy
Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more
CP Wire
Mon, 04/3/23 - 03:35 pm
Tags:
CVS Health, Signify Health, M&A, Ferring Pharmaceuticals, Pfizer, Bristol Myers Squibb, Eli Lilly, Novo Nordisk, Boehringer Ingelheim, Jardiance, Ozempic, drug pricing, Eliquis, CMS
Mon, 04/3/23 - 03:26 pm
Tags:
CVS Health, Signify Health, M&A, Ferring Pharmaceuticals, Pfizer, Bristol Myers Squibb, Eli Lilly, Novo Nordisk, Boehringer Ingelheim, Jardiance, Ozempic, drug pricing, Eliquis, CMS
Lilly says experimental Alzheimer's drug reduces amyloid in small study
Reuters
Mon, 04/3/23 - 09:54 am
Tags:
Eli Lilly, Alzheimer's disease, clinical trials, remternetug
Go or no go? Seagen's Padcev eyes FDA approval
EP Vantage
Mon, 04/3/23 - 09:41 am
Tags:
FDA, AbbVie, Alvotech, Ascendis Pharma, Astellas, AstraZeneca, Biogen, Daiichi Sankyo, Eli Lilly, Ferring Pharmaceuticals, Hugel, Innoviva, Ionis Pharmaceuticals, Lundbeck, Merck, Novo Nordisk, Otsuka, Pfizer, Roche Seagen, Seres Therapeutics, Takeda, UCB, Vertex Pharmaceuticals
CHMP gives thumbs-up for Wegovy use in adolescents, along with nine new drug recommendations
Endpoints
Sun, 04/2/23 - 04:17 pm
Tags:
EMA, Europe, CHMP, Wegovy, Novo Nordisk, Bimervax, TG Therapeutics, Eli Lilly, Bristol Myers Squibb, Novartis, AstraZeneca
Boehringer Ingelheim and Eli Lilly's Jardiance gets big lift from heart failure indications
Fierce Pharma
Wed, 03/29/23 - 04:01 pm
Tags:
Boehringer Ingelheim, Eli Lilly, Jardiance, heart failure
Top 10 pharma R&D budgets in 2022
Fierce Biotech
Mon, 03/27/23 - 10:21 pm
Tags:
R&D, Roche, JNJ, Merck, Pfizer, Novartis, AstraZeneca, Bristol Myers Squibb, Eli Lilly, Sanofi, AbbVie
Eli Lilly to increase investment to $1B into new Irish manufacturing facility — report
Endpoints
Mon, 03/27/23 - 09:55 pm
Tags:
Eli Lilly, Ireland, drug manufacturing
Novo's high-dose Rybelsus win tees up regulatory filings—and new rivalries
Fierce Pharma
Mon, 03/27/23 - 11:23 am
Tags:
Novo Nordisk, Rybelsus, diabetes, clinical trials, Eli Lilly
Will Eli Lilly Be a Trillion-Dollar Stock by 2030?
Motley Fool
Thu, 03/23/23 - 11:35 am
Tags:
Eli Lilly, Mounjaro
Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
PM Live
Wed, 03/22/23 - 10:15 am
Tags:
Roche, Eli Lilly, Alzheimer's disease, diagnostics
Flare fires up with $123M series B to target transcription factors with 3 Big Pharmas in tow
Fierce Biotech
Wed, 03/22/23 - 10:13 am
Tags:
Flare Therapeutics, funding, Pfizer, Eli Lilly, Novartis, transcription factors
AACR 2023 – Moderna's immunotherapeutic splash
EP Vantage
Wed, 03/22/23 - 10:03 am
Tags:
AACR, Moderna Therapeutics, Allogene, AstraZeneca, Merck, Roche, Novartis, Eli Lilly, Innovent, Springworks, Biogene, Relay Therapeutics, Vivace Therapeutics
Eli Lilly signs CSO Daniel Skovronsky to $5M non-compete clause
Medical Marketing and Media
Mon, 03/20/23 - 09:47 am
Tags:
Eli Lilly, executives, Daniel Skovronsky, CSO
Three's company: Sanofi follows lead of Lilly and Novo, slashes insulin price by 78% and caps out-of-pocket costs
Endpoints
Thu, 03/16/23 - 09:16 pm
Tags:
Sanofi, Lantus, insulin, diabetes, drug pricing, Eli Lilly, Novo Nordisk
SEC says Eli Lilly can't avoid requests for more info on diversity efforts, abortion stance
Endpoints
Thu, 03/16/23 - 07:00 pm
Tags:
Eli Lilly, SEC, abortion, diversity, DEI, Indiana

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.